Pages that link to "Q34435656"

The following pages link to The survival motor neuron protein in spinal muscular atrophy (Q34435656):

Displaying 50 items.

• Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs (Q21142695) (← links)
• WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies (Q21145787) (← links)
• Spinal muscular atrophy (Q21202863) (← links)
• A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing (Q22008514) (← links)
• Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems (Q22010941) (← links)
• Coiled bodies and gems: Janus or gemini? (Q22066143) (← links)
• Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli (Q22253358) (← links)
• Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein (Q24291073) (← links)
• The Gemin5 protein of the SMN complex identifies snRNAs (Q24297645) (← links)
• The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. (Q24307665) (← links)
• Coupled in vitro import of U snRNPs and SMN, the spinal muscular atrophy protein (Q24307701) (← links)
• Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics (Q24311585) (← links)
• ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies (Q24519083) (← links)
• SMN interacts with a novel family of hnRNP and spliceosomal proteins (Q24535803) (← links)
• Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number. (Q24539804) (← links)
• SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR (Q24599124) (← links)
• Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein (Q24600358) (← links)
• The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy (Q24604444) (← links)
• Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism (Q24613087) (← links)
• Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues (Q24651106) (← links)
• A SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA mice (Q24657021) (← links)
• A functional interaction between the survival motor neuron complex and RNA polymerase II (Q24674951) (← links)
• Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy (Q26741506) (← links)
• Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases (Q26750803) (← links)
• Spinal muscular atrophy: from gene discovery to clinical trials (Q26824894) (← links)
• Homeostatic plasticity at the Drosophila neuromuscular junction (Q26829672) (← links)
• Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy (Q26864605) (← links)
• Neuronal RNA-binding proteins in health and disease (Q26866130) (← links)
• The function of RNA-binding proteins at the synapse: implications for neurodegeneration (Q26991684) (← links)
• Stem Cell Transplantation for Motor Neuron Disease: Current Approaches and Future Perspectives (Q26995278) (← links)
• Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy (Q27328843) (← links)
• The spinal muscular atrophy disease protein SMN is linked to the Golgi network (Q27329644) (← links)
• A large animal model of spinal muscular atrophy and correction of phenotype (Q27340106) (← links)
• In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein (Q28116617) (← links)
• Abnormal fatty acid metabolism in childhood spinal muscular atrophy (Q28138438) (← links)
• The survival motor neuron protein interacts with the transactivator FUSE binding protein from human fetal brain (Q28139765) (← links)
• Exclusion of Htra2-beta1, an up-regulator of full-length SMN2 transcript, as a modifying gene for spinal muscular atrophy (Q28142479) (← links)
• Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy (Q28177632) (← links)
• Cajal body proteins SMN and Coilin show differential dynamic behaviour in vivo (Q28189028) (← links)
• The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1 (Q28213183) (← links)
• SMN-independent subunits of the SMN complex. Identification of a small nuclear ribonucleoprotein assembly intermediate (Q28237155) (← links)
• The protective effects of beta-lactam antibiotics in motor neuron disorders (Q28241331) (← links)
• The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells (Q28242279) (← links)
• Induction of full-length survival motor neuron by polyphenol botanical compounds (Q28254983) (← links)
• Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts (Q28261807) (← links)
• Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery (Q28288188) (← links)
• Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice (Q28288250) (← links)
• Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition (Q28288824) (← links)
• Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy (Q28289793) (← links)
• The SMN complex: an assembly machine for RNPs (Q28294580) (← links)